Clinical Trials on Primary Hyperoxaluria Type 1 in United Kingdom
Total 6802 results
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)France, United Kingdom, Netherlands, Israel, Germany
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Allena PharmaceuticalsCompletedEnteric Hyperoxaluria | Primary Hyperoxaluria | HyperoxalemiaUnited States, United Kingdom, Germany
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary Hyperoxaluria Type 3United States, Germany, Netherlands, United Kingdom
-
Alnylam PharmaceuticalsRecruitingPrimary Hyperoxaluria Type 1France, Spain, United States, Israel, Belgium, Switzerland, Germany, United Kingdom, Italy, Canada
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
OxTheraFP7-SME-2013 Research for the benefit of SMEs programCompletedPrimary HyperoxaluriaFrance, Germany, United Kingdom
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary HyperoxaluriaUnited States, France, Germany, Netherlands, United Kingdom
-
OxTheraTerminatedHyperoxaluria, PrimaryUnited Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
OxTheraCompletedPrimary HyperoxaluriaFrance, United Kingdom, Spain, Belgium, United States, Germany, Tunisia
-
VA New York Harbor Healthcare SystemMayo Clinic; New York UniversityUnknownOxalate, Primary Hyperoxaluria, MicrobiomeUnited States
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGTFrance, United Kingdom, Netherlands, Israel, Germany
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Orphan...CompletedHyperoxaluriaUnited States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedHyperoxaluria | Enteric HyperoxaluriaUnited States
-
Mayo ClinicCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Oxalosis...Completed
-
OxTheraCompletedPrimary HyperoxaluriaUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
Mayo ClinicNational Institutes of Health (NIH); Oxalosis and Hyperoxaluria Foundation...WithdrawnKidney Stones | Nephrocalcinosis | Primary HyperoxaluriaUnited States
-
Allena PharmaceuticalsCompletedNephrolithiasis | Kidney Stones | Hyperoxaluria | Secondary Hyperoxaluria | Dietary HyperoxaluriaUnited States
-
Imperial College LondonCompleted
-
Imperial College LondonOxford Brookes University; Institut d'Investigació Biomèdica de Girona Dr.... and other collaboratorsCompletedType1 Diabetes MellitusUnited Kingdom
-
Imperial College LondonDexCom, Inc.UnknownType 1 Diabetes MellitusUnited Kingdom
-
University of SurreyMedical University of Graz; KU Leuven; University of Cambridge; UK Civil Aviation... and other collaboratorsRecruiting
-
University of BristolDiabetes UKCompleted
-
Northampton General Hospital NHS TrustActive, not recruitingType 1 Diabetes MellitusUnited Kingdom
-
King's College LondonCompletedType 1 Diabetes Mellitus | LipohypertrophyUnited Kingdom
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Nottingham University... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom
-
Liverpool Hope UniversityCompleted
-
Queen's University, BelfastWithdrawn
-
NHS LothianNHS Tayside; DexCom, Inc.RecruitingType 1 Diabetes MellitusUnited Kingdom
-
SynlogicCompletedHealthy | Enteric HyperoxaluriaUnited States
-
Allena PharmaceuticalsCompletedNephrolithiasis | Kidney Stones | Hyperoxaluria | Secondary Hyperoxaluria | Dietary HyperoxaluriaUnited States
-
University of CambridgeDiabetes UKCompletedType 1 Diabetes MellitusUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompletedType 1 Diabetes | Type 1 Diabetes Mellitus Maturity OnsetUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; Leiden University Medical CenterCompletedType 1 Diabetes MellitusNetherlands, United Kingdom
-
King's College LondonKing's College Hospital NHS Trust; Juvenile Diabetes Research Foundation; Guy... and other collaboratorsCompletedHypoglycemia | Type 1 Diabetes MellitusUnited States, United Kingdom
-
University of CambridgeMedical University of Graz; University Hospital Birmingham NHS Foundation Trust and other collaboratorsCompletedHypoglycemia | Type 1 Diabetes Mellitus | ArrythmiaUnited Kingdom
-
Northumbria UniversityNewcastle UniversityCompleted
-
Newcastle UniversitySanofi; Medtronic; Newcastle-upon-Tyne Hospitals NHS Trust; Newcastle Primary Care...Completed
-
Imperial College LondonCompletedType 1 Diabetes | Type 2 DiabetesUnited Kingdom